Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy
Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) a...
Uložené v:
| Vydané v: | Cancer research (Chicago, Ill.) Ročník 77; číslo 18; s. 5054 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
15.09.2017
|
| Predmet: | |
| ISSN: | 1538-7445, 1538-7445 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O
, O
consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O
in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O
and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419.
. |
|---|---|
| AbstractList | Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O
, O
consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O
in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O
and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419.
. Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O2•-, O2 consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O2•- in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O2•- and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. Cancer Res; 77(18); 5054-67. ©2017 AACR.Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger patients. The current study demonstrates that exponentially growing fibroblasts from elderly (old) male donor subjects (70, 72, and 78 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemotherapy and IR (∼70%-80% killing) relative to young fibroblasts (5 months and 1 year; ∼10%-20% killing) and adult fibroblasts (20 years old; ∼10%-30% killing). Old fibroblasts also displayed significantly increased (2-4-fold) steady-state levels of O2•-, O2 consumption, and mitochondrial membrane potential as well as significantly decreased (40%-50%) electron transport chain (ETC) complex I, II, IV, V, and aconitase (70%) activities, decreased ATP levels, and significantly altered mitochondrial structure. Following adenoviral-mediated overexpression of SOD2 activity (5-7-fold), mitochondrial ETC activity and aconitase activity were restored, demonstrating a role for mitochondrial O2•- in these effects. Old fibroblasts also demonstrated elevated levels of endogenous DNA damage that were increased following treatment with IR and chemotherapy. Most importantly, treatment with the small-molecule, superoxide dismutase mimetic (GC4419; 0.25 μmol/L) significantly mitigated the increased sensitivity of old fibroblasts to IR and chemotherapy and partially restored mitochondrial function without affecting IR or chemotherapy-induced cancer cell killing. These results support the hypothesis that age-associated increased O2•- and resulting DNA damage mediate the increased susceptibility of old fibroblasts to IR and chemotherapy that can be mitigated by GC4419. Cancer Res; 77(18); 5054-67. ©2017 AACR. |
| Author | Strack, Stefan Goswami, Prabhat C Riley, Dennis P Furqan, Muhammad Allen, Bryan G Schoenfeld, Joshua D Buatti, John M Hejleh, Taher Abu Mapuskar, Kranti A Flippo, Kyle H Domann, Frederick E Spitz, Douglas R Monga, Varun |
| Author_xml | – sequence: 1 givenname: Kranti A surname: Mapuskar fullname: Mapuskar, Kranti A organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 2 givenname: Kyle H surname: Flippo fullname: Flippo, Kyle H organization: Department of Pharmacology, The University of Iowa, Iowa City, Iowa – sequence: 3 givenname: Joshua D surname: Schoenfeld fullname: Schoenfeld, Joshua D organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 4 givenname: Dennis P surname: Riley fullname: Riley, Dennis P organization: Galera Therapeutics, Inc., Malvern, Pennsylvania – sequence: 5 givenname: Stefan surname: Strack fullname: Strack, Stefan organization: Department of Pharmacology, The University of Iowa, Iowa City, Iowa – sequence: 6 givenname: Taher Abu surname: Hejleh fullname: Hejleh, Taher Abu organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa – sequence: 7 givenname: Muhammad surname: Furqan fullname: Furqan, Muhammad organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa – sequence: 8 givenname: Varun surname: Monga fullname: Monga, Varun organization: Department of Internal Medicine, The University of Iowa, Iowa City, Iowa – sequence: 9 givenname: Frederick E surname: Domann fullname: Domann, Frederick E organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 10 givenname: John M surname: Buatti fullname: Buatti, John M organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 11 givenname: Prabhat C surname: Goswami fullname: Goswami, Prabhat C organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 12 givenname: Douglas R surname: Spitz fullname: Spitz, Douglas R organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa – sequence: 13 givenname: Bryan G surname: Allen fullname: Allen, Bryan G email: bryan-allen@uiowa.edu organization: Department of Radiation Oncology, The University of Iowa, Iowa City, Iowa. bryan-allen@uiowa.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28765155$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtPwzAQhC1URB_wE0A-ckmxEztOjlGhtFIBice52sRbapTEwXYkyq8nEkXisrOHb0aamZJRa1sk5JKzOecyu2GMZZEUKp4viseIq4hxlp6QCZdJFikh5OjfPyZT7z8Gi-RMnpFxnKlUcikn5PvBBFvtbaudgZq-9B06-2U00nVbOQSPnhbvGBXe28pAQD0wvsIumNLUJhyo3dFV30BLb9E1Q8TSlM6WNfjgabD0GfRgM7al0Gq62GNjwx4ddIdzcrqD2uPFUWfkbXn3ulhFm6f79aLYRJVkMkSJSCqBOgMFeT5clfBEYYKQ7UqRM1GKMhUlgNZaZcArZOlAiVgzrTCVcTwj17-5nbOfPfqwbczQoK6hRdv7Lc9jKTlnnA_o1RHtywb1tnOmAXfY_u0V_wA2WnHg |
| CitedBy_id | crossref_primary_10_1016_j_freeradbiomed_2019_11_012 crossref_primary_10_1016_j_jksus_2021_101655 crossref_primary_10_1016_j_isci_2023_106314 crossref_primary_10_1155_2018_2468457 crossref_primary_10_1093_cercor_bhz052 crossref_primary_10_3390_ijms25168885 crossref_primary_10_1161_JAHA_124_039216 crossref_primary_10_1016_j_freeradbiomed_2025_09_013 crossref_primary_10_1126_scitranslmed_abb3768 crossref_primary_10_1007_s00249_020_01460_x crossref_primary_10_1142_S0192415X22500586 crossref_primary_10_1667_RR15101_1 crossref_primary_10_1016_j_cmet_2020_09_012 crossref_primary_10_3390_antiox10091329 crossref_primary_10_1172_JCI120844 crossref_primary_10_1007_s00210_023_02559_6 crossref_primary_10_1080_09553002_2021_1956007 crossref_primary_10_1016_j_semradonc_2018_10_005 crossref_primary_10_2147_DDDT_S267400 crossref_primary_10_3390_antiox13050587 crossref_primary_10_1016_j_redox_2018_09_020 crossref_primary_10_1016_j_cell_2022_12_027 crossref_primary_10_3389_fmolb_2025_1638042 crossref_primary_10_1016_j_drudis_2023_103626 crossref_primary_10_1016_j_freeradbiomed_2020_07_032 crossref_primary_10_1155_2019_4278658 crossref_primary_10_3390_antiox7010018 crossref_primary_10_1089_ars_2023_0491 |
| ContentType | Journal Article |
| Copyright | 2017 American Association for Cancer Research. |
| Copyright_xml | – notice: 2017 American Association for Cancer Research. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1158/0008-5472.CAN-17-0106 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-7445 |
| ExternalDocumentID | 28765155 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: P30 ES005605 – fundername: NCI NIH HHS grantid: T32 CA078586 – fundername: NIGMS NIH HHS grantid: T32 GM007337 – fundername: NCI NIH HHS grantid: R01 CA182804 – fundername: NCI NIH HHS grantid: R01 CA111365 – fundername: NCI NIH HHS grantid: P30 CA086862 – fundername: NINDS NIH HHS grantid: R01 NS056244 |
| GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 53G 5GY 5RE 5VS 6J9 AAJMC ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AETEA AFHIN AFOSN AFRAH AFUMD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 EBS ECM EIF EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO NPM OK1 P0W P2P PQQKQ RCR RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ 7X8 AAFWJ ABUFD |
| ID | FETCH-LOGICAL-c505t-343c4ed8a7a998a773137e3ea8fb4904b4b64baaddd78a1ce068a742d0d7e6522 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000410945700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1538-7445 |
| IngestDate | Sun Nov 09 10:10:08 EST 2025 Thu Apr 03 07:11:27 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 18 |
| Language | English |
| License | 2017 American Association for Cancer Research. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c505t-343c4ed8a7a998a773137e3ea8fb4904b4b64baaddd78a1ce068a742d0d7e6522 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://cancerres.aacrjournals.org/content/canres/77/18/5054.full.pdf |
| PMID | 28765155 |
| PQID | 1925511011 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1925511011 pubmed_primary_28765155 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-09-15 |
| PublicationDateYYYYMMDD | 2017-09-15 |
| PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cancer research (Chicago, Ill.) |
| PublicationTitleAlternate | Cancer Res |
| PublicationYear | 2017 |
| References | 19426871 - Methods Enzymol. 2009;457:231-53 13738472 - J Biol Chem. 1960 Nov;235:3322-9 15134509 - Curr Med Chem. 2004 May;11(9):1105-12 16885361 - Cancer Res. 2006 Aug 1;66(15):7615-20 4354035 - Arch Biochem Biophys. 1973 Sep;158(1):396-400 19803744 - Antioxid Redox Signal. 2010 Jun 15;12(12):1431-70 17242670 - Cancer Control. 2007 Jan;14(1):44-56 5016631 - J Am Geriatr Soc. 1972 Apr;20(4):145-7 17406473 - Nat Protoc. 2006;1(5):2315-9 25706776 - Radiat Res. 2015 Mar;183(3):262-70 197811 - Adv Exp Med Biol. 1977;78:67-82 26184181 - Int J Mol Sci. 2015 Jul 13;16(7):15918-53 21050134 - Antioxid Redox Signal. 2011 Sep 15;15(6):1669-78 27794421 - J Invest Dermatol. 2017 Mar;137(3):576-586 19812404 - N Engl J Med. 2009 Oct 8;361(15):1475-85 25058905 - Eur J Pharmacol. 2014 Oct 5;740:364-78 23849169 - Radiother Oncol. 2013 Sep;108(3):362-9 8192914 - Biochem Med Metab Biol. 1994 Feb;51(1):35-42 21285760 - Plast Reconstr Surg. 2011 Feb;127(2):560-8 14907713 - J Biol Chem. 1951 Nov;193(1):265-75 7501808 - Radiother Oncol. 1995 Aug;36(2):107-20 23190879 - J Invest Dermatol. 2013 Apr;133(4):1088-96 12600822 - Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97 19929420 - Radiat Res. 2009 Dec;172(6):737-45 26636574 - PLoS One. 2015 Dec 04;10(12):e0143007 18610740 - In Vivo. 2008 May-Jun;22(3):305-9 2547324 - Anal Biochem. 1989 May 15;179(1):8-18 22334657 - J Biol Chem. 2012 Mar 30;287(14):10990-1001 22689576 - J Biol Chem. 2012 Aug 3;287(32):27255-64 8761419 - Carcinogenesis. 1996 Aug;17(8):1633-9 13096460 - J Appl Physiol. 1953 Sep;6(3):189-93 21659507 - J Biol Chem. 2011 Aug 5;286(31):27103-10 26589414 - Pharmacol Rev. 2016 Jan;68(1):20-48 11966833 - Eur J Cancer Care (Engl). 2002 Mar;11(1):33-43 9458810 - Am J Physiol. 1998 Jan;274(1 Pt 1):L127-33 16911562 - Aging Cell. 2006 Oct;5(5):379-89 17436562 - In Vivo. 2007 Mar-Apr;21(2):141-6 15197331 - Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):311-22 20195383 - Aging (Albany NY). 2009 May 22;1(6):557-72 23317514 - Curr Opin Genet Dev. 2013 Feb;23(1):53-62 14580310 - Antioxid Redox Signal. 2003 Oct;5(5):557-61 12054921 - Methods. 2002 Apr;26(4):307-16 22016654 - Int J Mol Sci. 2011;12(9):6226-39 11517304 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10469-74 19403886 - J Clin Oncol. 2009 Jun 10;27(17):2758-65 18508680 - Front Biosci. 2008 May 01;13:6554-79 27247702 - Oxid Med Cell Longev. 2016;2016:3565127 15647387 - Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50 |
| References_xml | – reference: 22689576 - J Biol Chem. 2012 Aug 3;287(32):27255-64 – reference: 19929420 - Radiat Res. 2009 Dec;172(6):737-45 – reference: 13096460 - J Appl Physiol. 1953 Sep;6(3):189-93 – reference: 19812404 - N Engl J Med. 2009 Oct 8;361(15):1475-85 – reference: 27247702 - Oxid Med Cell Longev. 2016;2016:3565127 – reference: 23849169 - Radiother Oncol. 2013 Sep;108(3):362-9 – reference: 22016654 - Int J Mol Sci. 2011;12(9):6226-39 – reference: 2547324 - Anal Biochem. 1989 May 15;179(1):8-18 – reference: 22334657 - J Biol Chem. 2012 Mar 30;287(14):10990-1001 – reference: 13738472 - J Biol Chem. 1960 Nov;235:3322-9 – reference: 14580310 - Antioxid Redox Signal. 2003 Oct;5(5):557-61 – reference: 4354035 - Arch Biochem Biophys. 1973 Sep;158(1):396-400 – reference: 26184181 - Int J Mol Sci. 2015 Jul 13;16(7):15918-53 – reference: 19426871 - Methods Enzymol. 2009;457:231-53 – reference: 16885361 - Cancer Res. 2006 Aug 1;66(15):7615-20 – reference: 17406473 - Nat Protoc. 2006;1(5):2315-9 – reference: 15647387 - Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50 – reference: 20195383 - Aging (Albany NY). 2009 May 22;1(6):557-72 – reference: 18610740 - In Vivo. 2008 May-Jun;22(3):305-9 – reference: 17436562 - In Vivo. 2007 Mar-Apr;21(2):141-6 – reference: 23317514 - Curr Opin Genet Dev. 2013 Feb;23(1):53-62 – reference: 19803744 - Antioxid Redox Signal. 2010 Jun 15;12(12):1431-70 – reference: 12054921 - Methods. 2002 Apr;26(4):307-16 – reference: 23190879 - J Invest Dermatol. 2013 Apr;133(4):1088-96 – reference: 7501808 - Radiother Oncol. 1995 Aug;36(2):107-20 – reference: 15197331 - Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):311-22 – reference: 21285760 - Plast Reconstr Surg. 2011 Feb;127(2):560-8 – reference: 14907713 - J Biol Chem. 1951 Nov;193(1):265-75 – reference: 197811 - Adv Exp Med Biol. 1977;78:67-82 – reference: 9458810 - Am J Physiol. 1998 Jan;274(1 Pt 1):L127-33 – reference: 5016631 - J Am Geriatr Soc. 1972 Apr;20(4):145-7 – reference: 11966833 - Eur J Cancer Care (Engl). 2002 Mar;11(1):33-43 – reference: 16911562 - Aging Cell. 2006 Oct;5(5):379-89 – reference: 8192914 - Biochem Med Metab Biol. 1994 Feb;51(1):35-42 – reference: 19403886 - J Clin Oncol. 2009 Jun 10;27(17):2758-65 – reference: 21659507 - J Biol Chem. 2011 Aug 5;286(31):27103-10 – reference: 17242670 - Cancer Control. 2007 Jan;14(1):44-56 – reference: 27794421 - J Invest Dermatol. 2017 Mar;137(3):576-586 – reference: 18508680 - Front Biosci. 2008 May 01;13:6554-79 – reference: 26636574 - PLoS One. 2015 Dec 04;10(12):e0143007 – reference: 15134509 - Curr Med Chem. 2004 May;11(9):1105-12 – reference: 12600822 - Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97 – reference: 8761419 - Carcinogenesis. 1996 Aug;17(8):1633-9 – reference: 25706776 - Radiat Res. 2015 Mar;183(3):262-70 – reference: 25058905 - Eur J Pharmacol. 2014 Oct 5;740:364-78 – reference: 11517304 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10469-74 – reference: 21050134 - Antioxid Redox Signal. 2011 Sep 15;15(6):1669-78 – reference: 26589414 - Pharmacol Rev. 2016 Jan;68(1):20-48 |
| SSID | ssj0005105 |
| Score | 2.4084754 |
| Snippet | Elderly cancer patients treated with ionizing radiation (IR) or chemotherapy experience more frequent and greater normal tissue toxicity relative to younger... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 5054 |
| SubjectTerms | Adult Age Factors Aged Animals Antineoplastic Agents - adverse effects Apoptosis - drug effects Apoptosis - radiation effects Cell Proliferation - drug effects Cell Proliferation - radiation effects Cells, Cultured Cisplatin - adverse effects Fibroblasts - drug effects Fibroblasts - pathology Fibroblasts - radiation effects Humans Male Membrane Potential, Mitochondrial - drug effects Membrane Potential, Mitochondrial - radiation effects Mice Mice, Inbred C57BL Mitochondria - drug effects Mitochondria - pathology Mitochondria - radiation effects Oxidative Stress Radiation, Ionizing Skin - drug effects Skin - pathology Skin - radiation effects Superoxide Dismutase - metabolism Superoxides - metabolism Young Adult |
| Title | Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28765155 https://www.proquest.com/docview/1925511011 |
| Volume | 77 |
| WOSCitedRecordID | wos000410945700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvAa7Sab7PYkpVq8NBQf0FvYZCdSkKSaVKy_3pkkpSdB8JLTBpbdb2a-2XkxdqWFiQMXPVWDxhIdFC1Q5rTnUGs4X4OKpZtWwyZUGOrxuDtqHtyKJq1yoRMrRW3zhN7Ib5CJoHFHAInb6btDU6MoutqM0FhlLQ-pDKFajZfdwv06hbESaiWl31TwCF9TAYN2fKnc634vdASlX3aC31lmZW0G2__d5w7bangm79XA2GUrkO2xjWETSd9n30MUZVR9mSUE8qcZNQz_mljgqDEoUR0K3nsFZ3F9YHFNUeXAVOm0c56nvIoA8DtS7m98gI53HiMZLwte5vyRmh7QrXOTWU59CZpar_kBexncP_cfnGYOg5MgPyodT3qJBKuNMuicGaXwrBV4YHQay25HxjIOZGxQU1qljUigE-Aq6dqOVRAgwTtka1mewTHjCpRGyuMbDYiCGBEkyGMBoVPkJbbbZpeLU40Q5xS8MBnksyJanmubHdVXE03rhhwRen000d0_-cPfp2zTJctMUyD8M9ZKUcrhnK0nn-Wk-LioAITfcDT8AbZ1z4s |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial+Superoxide+Increases+Age-Associated+Susceptibility+of+Human+Dermal+Fibroblasts+to+Radiation+and+Chemotherapy&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Mapuskar%2C+Kranti+A&rft.au=Flippo%2C+Kyle+H&rft.au=Schoenfeld%2C+Joshua+D&rft.au=Riley%2C+Dennis+P&rft.date=2017-09-15&rft.issn=1538-7445&rft.eissn=1538-7445&rft.volume=77&rft.issue=18&rft.spage=5054&rft_id=info:doi/10.1158%2F0008-5472.CAN-17-0106&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7445&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7445&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7445&client=summon |